Anthony Cleare
London
Professor of Psychiatry &
President of the International Society for Affective Disorders (ISAD)
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Anthony Cleare
Cost-effectiveness of pramipexole augmentation for acute phase and maintenance therapy of treatment-resistant depression compared to placebo augmentation: economic evaluation of the PAX-D randomised controlled trial
Keywords Treatment-resistant depression Pramipexole Cost-effectiveness analysis Health economics Quality of life Capabilities Evidence before this study Treatment-resistant depression (TRD) has substantial economic burden associated with increased direct medical and broader societal costs due to lost productivity and high informal care needs.
Pramipexole augmentation for the acute phase of treatment-resistant, unipolar depression: a placebo-controlled, double-blind, randomised trial in the UK
ArticlesOnline firstOpen access aDepartment of Psychiatry, University of Oxford, Oxford, UK bDepartment of Primary Care, University of Oxford, Oxford, UK cOxford Health NHS Foundation Trust, Oxford, UK dMerseycare NHS Foundation Trust, Liverpool, UK eInstitute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK fSouth London and Maudsley NHS Foundation Trust, London, UK gBristol Medical School, University of Bristol, Bristol, UK hCentre for Academic Mental Health,...
Predicting psychedelic-induced mystical experience intensity
Back to Journals » Neuropsychiatric Disease and Treatment » Volume 19 Authors Ko K , Carter B, Cleare AJ, Rucker JJ Received 16 June 2023 Accepted for publication 23 September 2023 Published 5 October 2023 Volume 2023:19 Pages 2105—2113 DOI https://doi.org/10.2147/NDT.S426193 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Roger Pinder Kwonmok Ko,1 Ben Carter,2 Anthony J Cleare,1,3 James J Rucker1,3 1Centre for...
A leaky umbrella has little value: evidence clearly indicates the serotonin system is implicated in depression - Molecular Psychiatry
|
A recent “umbrella” review examined various biomarkers relating to the serotonin system, and concluded there was no consistent evidence implicating serotonin in the pathophysiology of depression. We present reasons for why this conclusion is overstated, including methodological weaknesses in the review process, selective reporting of data, over-simplification, and errors in the interpretation of neuropsychopharmacological findings.
By Sameer Jauhar, Michael Bloomfield, Anthony Cleare, David Erritzoe, Cynthia Fu, Paolo Fusar-Poli, Guy Goodwin, Mario F. Juruena, Raymond W. Lam, Stephen M Lawrie, David Matuskey, Robert McCutcheon, David Nutt, Carmine Pariante, Toby Pillinger, Rajiv Radhakrishnan, James Rucker, Sudhakar Selvaraj, Rachel Upthegrove, Allan Young, Danilo Arnone, Phillip Corlett
|
Nature
Verified
Pharmacological management of depressive disorders
Abstract This article outlines current guidelines for the pharmacological treatment of depression, with an update based on recently published information. For acute treatment of moderate to severe depression in the absence of specific factors, the recommendation is treatment with a selective serotonin reuptake inhibitor or mirtazapine.
What do we know about long-term treatment outcomes for severe depressive disorders?
You are viewing a shared and read-only version of this article. We have detected that you have access to the full version. Please use the links below to access the full version with all functionality available (printing, copying, downloading, sharing).
Cortisol as a predictor of psychological therapy response in depressive disorders: systematic review and meta-analysis
You have accessRestricted access Cortisol as a predictor of psychological therapy response in depressive disorders: systematic review and meta-analysis Susanne Fischer, Rebecca Strawbridge, Andres Herane Vives, Anthony J. Cleare The British Journal of Psychiatry Feb 2017, 210 (2) 105-109; DOI: 10.1192/bjp.bp.115.180653
Cortisol as a predictor of psychological therapy response in depressive disorders: systematic review and meta-analysis
You have accessRestricted access Cortisol as a predictor of psychological therapy response in depressive disorders: systematic review and meta-analysis Susanne Fischer, Rebecca Strawbridge, Andres Herane Vives, Anthony J. Cleare The British Journal of Psychiatry Dec 2016, bjp.bp.115.180653; DOI: 10.1192/bjp.bp.115.180653
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines
Declaration of Conflicting Interests All attendees completed conflict of interest statements that are held at the British Association for Psychopharmacology office according to BAP policy.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Anthony
Contact Anthony, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack